Primary bone cancer and metastatic bone disease share a name but little else. Primary bone malignancies — osteosarcoma, chondrosarcoma, chordoma — are rare, accounting for fewer than 4,000 new cases annually in the United States. Metastatic bone disease is a different clinical reality entirely: approximately 400,000 new cases are diagnosed each year, driven by lung, prostate, breast, and kidney primaries spreading to bone. In older adults, a suspicious bone lesion is far more likely to represent metastasis than primary malignancy — a distinction that drives workup, treatment, and documentation in fundamentally different directions.
AAVBC's Bone Cancers Quick Reference Guide provides primary care clinicians with a structured reference for both disease categories. It covers the age-stratified workup pathway, primary bone cancer subtype recognition, ICD-10 coding for primary and secondary bone malignancies, pathologic fracture and spinal cord compression documentation, metastatic site coding paired with primary site, and MEAT documentation standards — grounded in current guideline evidence, and designed to help care teams respond accurately to one of the more diagnostically complex presentations in primary care.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of bone cancers — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Primary bone cancer and metastatic bone disease share a name but little else. Primary bone malignancies — osteosarcoma, chondrosarcoma, chordoma — are rare, accounting for fewer than 4,000 new cases annually in the United States. Metastatic bone disease is a different clinical reality entirely: approximately 400,000 new cases are diagnosed each year, driven by lung, prostate, breast, and kidney primaries spreading to bone. In older adults, a suspicious bone lesion is far more likely to represent metastasis than primary malignancy — a distinction that drives workup, treatment, and documentation in fundamentally different directions.
AAVBC's Bone Cancers Quick Reference Guide provides primary care clinicians with a structured reference for both disease categories. It covers the age-stratified workup pathway, primary bone cancer subtype recognition, ICD-10 coding for primary and secondary bone malignancies, pathologic fracture and spinal cord compression documentation, metastatic site coding paired with primary site, and MEAT documentation standards — grounded in current guideline evidence, and designed to help care teams respond accurately to one of the more diagnostically complex presentations in primary care.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of bone cancers — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
